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Abstract 
The anti-viral and membrane fusion inhibitor, carbobenzoxy-D-phenylalanine-L-phenylalanine-glycine (ZfFG), was studied in phospho- 
lipid bilayers, where earlier studies had indicated this peptide functioned. Multinuclear magnetic resonance (NMR) studies were 
performed with isotopically labeled peptide. A peptide labeled in the glycine carboxyl with 13C was synthesized, and the isotropic 
laC-NMR chemical shift of that carbon was measured as a function of pH. A pK a of 3.6 for the carboxyl was determined from the 
peptide bound to a phosphatidylcholine bilayer. ZfFG inhibits the formation by sonication of highly curved, small unilamellar vesicles. 
Experiments as a function of pH revealed that this ability of ZfFG was governed by a pK a of 3.7. Therefore the protonation state of the 
carboxyl of ZfFG appeared to regulate the effectiveness of this anti-viral peptide at destabilizing highly curved phospholipid assemblies. 
Such destabilization had previously been discovered to be related to the mechanism of the anti-fusion and anti-viral activity of this 
peptide. The location of the carboxyl of ZfFG in the membrane was probed with paramagnetic relaxation enhancement of the 13C spin 
lattice relaxation of the carboxyl carbon in the glycine of ZfFG (enriched in 13C). Results suggested that this carboxyl is at or above the 
surface of the phospholipid bilayer. The dynamics of the molecule in the membrane were examined with 2H-NMR studies of ZfFG, 
deuterated in the a-carbon protons of the glycine. When ZfFG was bound to membranes of phosphatidylcholine, a sharp 2H-NMR 
spectral component was observed, consistent with a disordering of the glycine methylene segment of the peptide. When ZfFG was bound 
to N-methyl dioleoylphosphatidylethanolamine (N-m thyl DOPE) bilayers at temperatures below 30 ° C, a large quadrupole splitting was 
observed. These results suggest hat ZfFG likely inhibits membrane fusion from the surface of the lipid bilayer, but not by forming a 
tight, stoichiometric complex with the phospholipids. 
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1. Introduction 
The anti-viral peptide, carbobenzoxy-D-phenylalanine- 
L-phenylalanine-glycine (ZfFG) was observed to inhibit 
viral infection of the paramyxoviruses including Sendai, 
measles, CDV, and SV5 [1]. Recent studies revealed that 
this peptide inhibited viral infection, both Sendai and 
measles, by inhibiting membrane fusion, a required step in 
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viral entry [2-4]. Membrane fusion was inhibited by ZfFG 
in Sendai fusion with erythrocyte ghosts, Sendai fusion 
with large unilamellar vesicles (LUV) of N-methyl di- 
oleoylphosphatidylethanolamine (N-methyl DOPE), and 
fusion of LUV of N-methyl DOPE, and fusion of measles 
with cells. The inhibition of fusion was specific for the 
primary structure of the anti-viral peptide. The same struc- 
tural specificity observed in inhibition of viral infection 
was also observed in the inhibition of membrane fusion by 
these anti-viral peptides. More recently, the inhibition of 
membrane fusion by ZfFG was correlated with an inhibi- 
tion of the formation of highly curved phospholipid sur- 
faces [5], including those found in hexagonal II phases [6]. 
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Such observations suggested that the inhibition of mem- 
brane fusion was due to the inhibition of the formation of 
intermediates on the fusion pathway that incorporated 
highly curved phospholipid surfaces in their structure. In 
particular, ZfFG altered the packing of lipids in the mem- 
brane, favoring relatively flat bilayer structures and desta- 
bilizing highly curved phospholipid assemblies [5]. 
As part of a process designed to better understand the 
molecular mechanism by which the ZfFG and related 
peptides inhibited membrane fusion, we studied the behav- 
ior of the peptide itself in phospholipid bilayers, using 
isotopically labeled peptide and multinuclear magnetic res- 
onance (NMR). Using 13C-enriched peptide, the pK a was 
determined for the terminal carboxyl of the peptide, in the 
membrane. ZfFG inhibits the formation of highly curved, 
small unilamellar vesicles by sonication. Experiments as a 
function of pH revealed that this ability of ZfFG was 
governed by a pK a that was the same as that for the 
ionization reaction of the terminal carboxyl. Some infor- 
mation was obtained about the location of the peptide by 
measuring the paramagnetic enhancement of spin lattice 
relaxation from a spin label in the membrane, using the 
same 13C-enriched peptide and the observable 13C reso- 
nances from the lipid in the bilayer. Results suggested that 
this carboxyl was near the surface of the phospholipid 
bilayer. The dynamics of the peptide were explored with 
2H-NMR of a specifically deuterated peptide in phospho- 
lipid bilayers. The peptide was disordered under conditions 
where fusion inhibition had previously been observed. 
2. Materials and methods 
Egg phosphatidylcholine (PC), dipalmitoylphospha- 
tidylcholine (DPPC) and N-methyl dioleoylphos- 
phatidylethanolamine (N-methyl DOPE) were obtained 
from Avanti Polar Lipids (Birmingham, AL). Carboben- 
zoxy-D-Phe-L-PheGly (Z-D-Phe-L-PheGly) and carboben- 
zoxy-Gly-L-Phe were purchased from Sigma (St. Louis, 
MO). All chemicals and solvents were of the highest purity 
available and used without further purification. Carboben- 
zoxy (Z)-o-phenylalanine and L-phenylalanine-OMe hy- 
drochloride, 1-hydroxybenzotriazole (HOBt), 1-ethyl-3- 
(3-dimethylaminopropyl) carbodiimide (EDC), isobutyl 
chloroformate, N-methylmorpholine, triethylamine and 
other reagents for peptide synthesis were from Sigma (St. 
Louis, MO). Thionyl chloride was from Aldrich (Milwau- 
kee, WI). Isotopically labelled residues, 2H-GIy (d 5, 98%) 
and 13C'-Gly (C1, 99%), were from Cambridge Isotopes 
(Woburn, MA). 
2.1. Phosphate assay 
Phosphate was determined by published procedures 
(Bartlett [18]). 
2.2. Peptide synthesis and purification 
Isotopically labelled residues, 2H-Gly (2,2-d2, 98%) 
and 13C-Gly (C1, 99%) were esterified [7]. The peptide 
Z-D-Phe-L-Phe-OMe was synthesized using standard 
carbodiimide/1-hydroxybenzotriazole mediated coupling 
[8]. Base catalyzed hydrolysis of alkyl esters was em- 
ployed for carboxyl deprotection and the addition of a 
labelled Gly-OMe residue was accomplished using an 
isobutylcarbonic a id mixed anhydride coupling procedure 
[9]. The peptides were purified and analyzed on an Altex 
semiprep reverse-phase C18 column (10 × 250 mm) cou- 
pled to a guard column (10 × 50 mm) employing an 
acetonitrile/water (each with 0.1% TFA) linear gradient 
elution (flow rate: 1.5 ml min -1) mode with detection at 
230 nm. The purity of the labelled peptides was further 
confirmed by thin-layer chromatography using three differ- 
ent solvent systems (CHCI3 /MeOH (95:5), n- 
BuOH/HOAc/HzO (4:1:1) and CHCIa/EtOH (9:1)) with 
iodine stain for detection. Commercially available ZfFG 
(Sigma) was run in parallel with the 13C- and 2H-labelled 
peptides. The 1H- and 13C-NMR spectra of the peptides 
were consistent with their primary structure. 
2.3. Vesicle preparation 
Large unilamellar vesicles (LUV) were prepared ac- 
cording to methods described previously [10] with further 
details described by Ellens et al. [11]. The phospholipid 
was hydrated for 3 h on ice, under N 2 in the indicated 
buffer. The lipid suspension was next subjected to 5 
freeze-thaw cycles followed by 10 extrusions through a 
polycarbonate membrane with 0.1 /zm pores (Nuclepore, 
Pleasanton, CA). Vesicles were stored on ice, under N 2 
and were used within 1 day. Vesicles were characterized 
by negative stain transmission electron microscopy and by 
gel chromatography as a function of the number of extru- 
sions. After 10 extrusions, no further improvement in 
homogeneity of vesicle size was seen. Also, no evidence 
of multilamellar vesicles was observed. According to mea- 
surements of the electron micrographs, the LUV ranged in 
size from 200 nm to 900 nm, with most LUV near 400 nm. 
Encapsulation volume of the LUV was found to be approx- 
imately 12 /zl per/*mole of phospholipid. 
2.4. Sonication 
Sonication was performed with a Branson W350 probe 
sonicator with an ice bath at 0 ° C, with the probe tuned for 
the most efficient sonication (output control at 2, continu- 
ous output). First, multilamellar liposomes containing the 
peptide in the phospholipid bilayer were prepared in the 
following manner. Egg phosphatidylcholine and Z-D-Phe- 
L-PheGly were co-solubilized in chloroform/methanol 
(2:1) at room temperature in the indicated molar ratios. 
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The solvent was removed by evaporation under a stream of 
nitrogen gas followed by evaporation under high vacuum 
overnight. The material was then hydrated in H20 with 50 
mM NaC1 and 1 mM Hepes, 1 mM acetic acid, sealed 
under nitrogen gas and vortexed vigorously. The pH was 
adjusted to the desired value. The membranes were then 
treated with five minute sonications followed by a one 
minute rest period. The light scattering of the sample was 
determined as effective absorbance at 400 nm at each of 
the five minute timepoints. This process was repeated 
3-times, by which the static light scattering of a sample of 
egg PC without ZfFG had been reduced to a minimum 
value. The percentage of effective sonication was deter- 
mined by comparison of the sample containing ZfFG with 
the pure egg PC sample: ((initial light scattering of PC + 
ZfFG sample-  final light scattering of PC + ZfFG sam- 
ple)/(initial light scattering of pure PC sample-  final 
light scattering of pure PC sample)) × 100. 
multinuclear Fourier transform-NMR spectrometer, a3C- 
NMR (67 MHz) data were obtained on a Jeol FX270 
multinuclear Fourier transform-NMR spectrometer in 10 
mm tubes, using a 50 kHz window. 2048 data points were 
collected in the time domain. ~3C-NMR spectra were 
obtained with a Hahn echo (7r/2 = 7/xs) and a 1 s repeat 
time. For measurements of spin lattice relaxation time, the 
inversion-recovery sequence was used (T r -7 -7r /2 ) .  
Temperature was maintained by a computer-controlled air-
flow system. 
2.6. Data analysis 
The titration data were analyzed using a least squares fit 
of the appropriate sigmoidal equation, using SigmaPlot TM. 
3. Results 
2.5. NMR measurements 3.1. pg a of carboxyl of ZfFG 
2H-NMR spectra were recorded at 30.87 MHz on a 
' home-built' spectrometer. The ~-/2 pulse width was 3-4.5 
/xs, which is adequate power for the 2H-NMR spectra in 
the system investigated. A modified quadrupole cho se- 
quence was used for data acquisition [12]. Typically the 
value of 7 in the quadrupole cho sequence was 40 /xs, 
and the pulse sequence was normally repeated twice per 
second. Spectra were recorded 'on-resonance' using 
quadrature detection. Sample temperature was controlled 
by a computer-controlled liquid (ethylene glycol/H20) 
flow system, to an accuracy of less than 0.05 °C in a single 
coil probe head with a temperature gradient of less than 
0.F C across the sample. 
1H_NMR spectra were obtained at 400 MHz in a 5 mm 
probe using normal single pulse acquisitions on a Bruker 
5 
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Fig. 1. 67 MHz 13C-NMR spectra of egg PC LUV (50 mg) containing 
ZtFG labeled with 13C in the glycine carboxyl carbon (10 rag). Measure- 
ments were made in 1 mM Hepes, 50 mM NaC1, 1 mM EDTA. 6500 
transients were accumulated for each spectrum. Peak 1 arises from the 
13C-labeled carboxyl of the ZfFG, peak 2 arises from the vinyl carbons of 
the phospholipid, peak 4 from the N-methyls of the PC headgroup, peak 
5 from the methylenes of the hydrocarbon chains from the PC, and peak 6 
from the terminal methyl of the hydrocarbon chains. 
The carboxyl carbon of ZfFG was enriched to 99% in 
13C as described in Materials and methods, using 13C- 
labeled glycine. This labeled peptide was then incorporated 
into LUV of egg PC by co-solubilizing the peptide with 
the phospholipid in organic solvent prior to making the 
LUV. ~3C-NMR spectra were then obtained of this prepa- 
ration as a function of pH of the medium. The 13C-NMR 
spectrum of the LUV plus the 13C-labeled peptide showed 
a prominent resonance in the region of 173-176 ppm 
(depending upon pH) in addition to the phospholipid reso- 
nances, due to the carboxyl carbon of the ZfFG (resonance 
1 in Fig 1). The carbonyl resonances of the phospholipids 
underlay the resonance from the peptide and were not 
observable relative to the strong signal from the 13C-en- 
riched peptide carboxyl. Only the phospholipid carbonyl 
resonances were observed in samples without the labeled 
ZfFG. The isotropic 13C chemical shift of the peptide 
carboxyl resonance was measured as a function of pH. The 
results are presented in Fig. 2, which represent data from 
two independent experiments. A least squares fit of the 
data (see solid line in figure) indicates a pK a of the 
carboxyl of ZfFG of 3.6. 
3.2. Effect of pH on the ability of ZfFG to inhibit the 
formation of SUV 
Previously it was shown that, in the sonication of egg 
phosphatidylcholine to form small unilamellar vesicles 
(SUV), the presence of ZfFG was inhibitory [3,5]. Substan- 
tial inhibition was previously observed at 25 mol% ZfFG 
(with respect to the phospholipid component). Therefore in 
these experiments, 25 mol% ZfFG was added to egg 
phosphatidylcholine b fore hydration. The pH was ad- 
justed to the desired value for the experiments. As can be 
seen in Fig. 3, at pH 3 and 25 mol% ZfFG, a complete 














[ ]  
I I I I I 








3 4 5 
pH 
Fig. 2. Chemical shift of the 13C-NMR resonance from the glycine 
carboxyl carbon (13C-labeled) ofZfFG in egg PC LUV as a function of 
pH. The solid line is a fitted curve with a pK a of 3.6. Spectra were 
accumulated as in Fig. 1 and as described inMaterials and methods. 
pH 
Fig. 3. Effectiveness of ZfFG at inhibiting the formation of SUV by 
sonication as a function of pH, following the procedures described inthe 
text. The solid line is a fitted curve with a pK a of 3.7. 
inhibition of formation of SUV was observed (no de- 
tectable reduction in light scattering upon sonication as 
described in Materials and methods). This effect is reduced 
as the pH is increased, until at pH 5.5 and greater, a 
maximum of about 25% inhibition of the sonication pro- 
cess was recorded. The curve in Fig. 3 can be fit with a 
pK  a of 3.7. It should be noted that these data indicate an 
inhibition of the process of formation of SUV by sonica- 
tion at all pH values; however, the maximum effect was 
produced by ZfFG when the carboxyl was protonated. 
Thus at low pH, less peptide is required to inhibit forma- 
tion of SUV than at high pH. 
3.3. Relaxation enhancement of 13C T 1 of phospholipid and 
peptide resonances by the 16-doxyl spin label 
T 1 measurements were made on 13C resonances of egg 
PC and the 13C resonance of ZfFG labeled with 13C in the 
glycine carboxyl carbon, as a function of added spin label 
(the 16-doxyl fatty acid spin label). Measurements were 
made on LUV of egg PC containing labeled peptide at 20 
mole percent (peptide with respect o the phospholipids). 
The spin label was added prior to formation of the LUV. 
Higher resolution experiments with SUV were not possible 
due to the inhibition of the formation of SUV by ZfFG. 
Therefore, only clearly resolvable single carbon resonances 
were measured, including the N-methyl carbon resonance, 
the vinyl carbon resonances, and the terminal methyl car- 
bon resonance of the phosphatidylcholine. The T~ of these 
resonances in the absence of spin label and peptide were 
the same as reported previously [13]. The enhancement of
relaxation was then calculated according to the following 
equation: 
1 1 1 
~le = ~rls Tin 
where Tie is the enhancement of the relaxation t ime, Tls 
is the relaxation in the presence of spin label and Tin is the 
relaxation in the absence of spin label. Fig. 4 shows the 
relaxation enhancement of the resolvable individual car- 
bons in the 13C-NMR spectrum as a function of spin label 
concentration in the bilayer. (Since these measurements 
were made on LUV, the resonances were, in general, 
broad. Only the T 1 of those resonances of carbons that 
occurred with a chemical shift well removed from the 
other carbons were therefore measured.) At 3 mol% spin 
label, the effects were small and ambiguous. However, at 7 
mol% spin label, the relaxation enhancement of each of the 
carbons was clearly distinguishable from each of the other 
carbons. The most strongly perturbed resonance of the 
phospholipid was the vinyl resonance. At the highest spin 
label concentration used, the least perturbed T1 was that of 
the peptide carboxyl carbon. 
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Fig. 4. Relaxation enhancement, 1/Tie , for three carbons from PC and 
from the carboxyl carbon (13C-enriched) of the glycine of ZfFG, in LUV 
of egg PC, as a function of the mole percent added fatty acid spin label 
(C16). Measurements were made in the same buffer as in Fig. 1. ([2) 
ZfFG carboxyl carbon (glycine); (r,) terminal methyl carbons of the 
hydrocarbon chains of PC; (~) vinyl carbons of PC; (O) N-methyl 
carbons of PC. 
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Fig. 5. 30.87 MHz 2H-NMR spectra of a sample containing 2H-labeled ZfFG (10 mg) and N-methyl DOPE (37.5 mg) (peptide/phospholipid molar 
ratio = 2.5:1) dispersed in 250/.tl of 2H-depleted water with 1 mM Hepes, 50 mM NaCl, at pH 3: (A) 25.8 °C, (B) 29.7 °C, (C) 33.7 ° C and (D) 35.4 ° C. 
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Fig. 6. 400 MHz tH-NMR spectra of ZfFG added to preformed SUV of egg PC in 1 mM Hepes, 2H20 , and a small amount of CD3OH for addition of the 
peptide, at pH 7. The 1H resonances from the phenyl rings of the ZfFG are clearly visible in the vicinity of 8 ppm. Inset: expansion of the aromatic region 
showing the resonances from the aromatic protons of the ZfFG. 
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3.4. Behavior of ZfFG in phospholipid bilayers from 211- 
NMR spectra of 2H-labeled peptide 
previously that the peptide is bound to the membrane and 
is not free in solution [3]). 
ZfFG was labeled with 2H by synthesis with [2,2- 
2H 2 ]glycine. This peptide was incorporated into phospho- 
lipid bilayers composed of egg PC and in bilayers com- 
posed of N-methyl DOPE by co-solubilization in 
CHCI3/CH3OH before hydration to form MLV. The for- 
mer was used because it presented a stable lamellar phase 
and the latter lipid was used because of the ability of ZfFG 
to inhibit fusion of N-methyl DOPE LUV at temperatures 
above 35 ° C. 2H-NMR measurements were made in 2H-de- 
pleted media. The peptide content was (relative to the 
phospholipid content) modestly higher than the level of 
ZfFG required to maximally inhibit membrane fusion [2,3]. 
In egg PC bilayers, a sharp spectral component was ob- 
served from the deuterated ZfFG at all temperatures mea- 
sured (data not shown). In N-methyl DOPE bilayers, only 
a sharp spectral component was observed at temperatures 
of 35°C and above. At slightly lower temperatures 
(33.7 °C) a powder pattern with 90 ° edge singularities 
separated by 36 kHz was evident (Fig. 5C). At 29.7 °C, a 
powder pattern with splitting 50 + 1 kHz was observed 
(Fig. 5B). The intensity of this broad spectral component 
relative to the sharp spectral component increased with 
cooling until a temperature of 25 ° C was reached (Fig. 5A). 
The sharp spectral component did not disappear with 
further cooling but represented an insignificant proportion 
of the total signal. The peak probably arose from natural 
abundance deuterium in the buffer solute, Hepes, or from 
inadvertent exchange with atmospheric water during the 
sample manipulation. The spectral changes with tempera- 
ture described above were completely reversible. The re- 
suits were reproduced with two independent syntheses of 
the deuterated peptide. The unhydrated powder of the pure 
deuterated peptide was also recorded and exhibited a 
quadrupole splitting of 50 + 1 kHz (data not shown). 
3.5. Behavior of ZfFG in phospholipid bilayers from 1H- 
NMR spectra 
High resolution 400 MHz 1H-NMR spectra were ob- 
tained of ZfFG added to preformed SUV of egg PC. Under 
conditions of near neutral pH and limited amounts of 
added ZfFG (< 10 mol% with respect o the PC), such 
samples were observed to be metastable for several hours, 
sufficient o obtain the NMR spectra. (Over longer time 
periods, the SUV degraded and the suspension became 
turbid and unsuitable for high resolution-NMR studies. 
Lower pH and higher concentrations of ZfFG led to unac- 
ceptably high rates of degradation of the integrity of the 
SUV.) Fig. 6 shows a typical 1H-NMR spectrum of such a 
preparation. In addition to the resonances of the phospho- 
lipid, resonances arising from the phenyl rings of the ZfFG 
could be observed ownfield at about 8 ppm (the substan- 
tial broadening consistent with the conclusion reached 
4. Discussion 
The pK a of the carboxyl of the ZfFG was found to be 
3.6. The effectiveness of the ZfFG at inhibiting SUV 
formation was consistent with the ionization of the peptide 
carboxyl. The protonated form was the most effective 
under these conditions, although both the protonated and 
the unprotonated form were effective at interfering with 
the process of SUV formation. Previous work had revealed 
that ZfFG inhibited the formation of highly curved phos- 
pholipid assemblies. This work has indicated that the 
protonated form of the anti-viral peptide was the most 
potent inhibitor of the formation of curved surfaces. Per- 
haps the protonated form penetrated deeper into the mem- 
brane than the charged form of the peptide, thereby more 
strongly influencing the behavior of the phospholipids. 
The data on enhancement of 13C spin lattice relaxation 
indicates that the peptide carboxyl was well-removed from 
the center of the bilayer. Under the most simple of condi- 
tions, the paramagnetic enhancement of spin lattice relax- 
ation is inversely proportional to the sixth power of the 
distance between the 13C nucleus and the unpaired electron 
of the spin label. In this specific case, the relationship is
quantitatively a more complicated one, involving the lat- 
eral diffusion of the spin label and the peptide. However, 
this can be considerably simplified if one is interested only 
in the relative distances between known positions on the 
lipids and the spin label, compared to the distance between 
the 13C-labeled carboxyl and the spin label. 
1 1 
T1 e r-6 
where g(z) is the correlation function describing the time 
dependence of the dipolar interactions between the un- 
paired electron and the relevant 13C nucleus. This function 
is, in principle, complex due to the anisotropy of the 
relevant molecular dynamics and the lateral diffusion in 
the system [14]. However, if to a first approximation g(r) 
is the same for each of the nuclear spin-electron spin 
interactions involved (for example the influence of lateral 
diffusion would be expected to be similar for each of the 
interactions), then a comparison of l/T~e for different 
carbons will provide a measure of the ratio of the elec- 
tron-nuclear separation, r ( larger l/Tie corresponds to 
smaller ). 
The applicability of this relationship can be tested on 
the data from the 13C resonances from particular carbons 
of the phospholipid. With a spin label located in the 
interior of the bilayer, one would expect a stronger en- 
hancement, l/Tie , for the terminal methyl and the vinyl 
carbons than for the N-methyl carbons in the headgroup. 
As observed in Fig. 4, this expectation is fulfilled. Then 
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consideration of 1~Tie for the peptide carbonyl carbon 
shows that it is the least affected of the individual carbons 
measured. The 1~Tie for the carbonyl carbon is nearly an 
order of magnitude l ss than 1~Tie for the vinyl carbons, 
which are the closest o the position of the spin label in the 
bilayer. 1/TI~ for the peptide carbonyl carbon is less than 
1~Tie for the phosphatidylcholine N-methyl carbons. 
Quantitative comparisons need to be made carefully here, 
since the dynamics of the N-methyl carbons are different 
than the dynamics of the hydrocarbon chain carbons. How- 
ever, it is still reasonable to conclude that the peptide 
terminal carbonyl is most likely located on the surface of 
the membrane and not in the interior of the membrane. 
Such a conclusion is also consistent with the pK a of the 
carboxyl which is not indicative of a carbonyl buried in a 
medium of low dielectric onstant. A surface location for 
the terminal carbonyl is consistent with its strongly polar 
character. 
The 2H-NMR data on the 2H-labeled ZfFG showed no 
significant ordering of the peptide glycine when ZfFG was 
bound to bilayers of N-methyl DOPE at temperatures at 
which the peptide had been observed previously to inhibit 
membrane fusion of N-methyl DOPE LUV. In particular, 
at temperatures of 35°C and above, only a sharp spectral 
component was observed in the 2H-NMR of bilayers of 
N-methyl DOPE, characteristic of a disordered state of the 
peptide. Previous studies [2] showed that ZfFG inhibited 
membrane fusion of N-methyl DOPE LUV at temperatures 
of 35°C and above and fusion of Sendai virus with 
N-methyl DOPE LUV (fusion rates in these systems below 
35 ° C were too low to detect significant inhibition). 
At all temperatures, the 2H-NMR data showed a sharp 
spectral component from 2 H-labeled ZfFG in PC bilayers. 
ZfFG showed inhibition of Sendai fusion with erythrocyte 
ghosts at all temperatures between 25°C and 40°C [3], in 
which ZfFG was introduced into the outer leaflet of the 
erythrocyte, composed mainly of PC and sphingomyelin. 
Therefore it was unlikely that the peptide was oriented 
in the membrane analogously to the lipids or to cholesterol 
(director for axial diffusion perpendicular to the membrane 
surface) as part of the mechanism of inhibition of mem- 
brane fusion. Such a location would be likely to produce 
measurable quadrupole splittings from the deuterated posi- 
tions due to additional restriction on modes of motion of 
the peptide, imposed by the ordering of the membrane 
structure. Rather the observed ynamic behavior was con- 
sistent with a location of the peptide on the surface of the 
membrane. 
There is an alternative xplanation for the 2H-NMR 
data that cannot be ruled out on the basis of these studies 
alone: a time-averaged orientation of the C-D bond seg- 
ments at the 'magic angle' with respect o the director for 
axial diffusion leading to the observed sharp spectral com- 
ponent. However, high resolution 1H-NMR measurements 
of ZfFG added to preformed SUV of egg PC showed 
observable, though broadened, resonances due to the phenyl 
rings of the peptide (Fig. 6), supporting the suggestion 
above that the peptide was disordered in the membrane 
surface. For comparison, no 1H-NMR resonances were 
observed from the motionally ordered portions of choles- 
terol in SUV of PC [15]. Furthermore, it should be noted 
that the available evidence suggests that the peptide is 
largely bound to the membrane (and not in solution, where 
an isotropic resonance would result). A complex of the 
peptide with phospholipid, forming a mixed micelle and 
producing an isotropic resonance, can be ruled out on the 
basis of the 31p-NMR data which does not show an 
isotropic omponent for the phospholipids [3]. 
At temperatures below 35 ° C, a highly ordered compo- 
nent was observed from the ZfFG in bilayers of N-methyl 
DOPE. These 2H-NMR data indicated that the ZfFG had 
access to at least two 'sites' in the sample at low tempera- 
ture and that there was an equilibrium of ZfFG distribution 
between these two sites. The similarity of the quadrupole 
splittings from [2,2 d 2 gly]ZfFG in N-methyl DOPE at 
25 ° C and the splitting from the pure [2,2 d 2 gly]ZfFG in a 
powder suggested that the peptide was excluded from the 
N-methyl DOPE bilayer at low temperature. Perhaps this 
could have been the result of increased hydrogen bonding 
between the quaternary amines and the phosphate of a 
neighboring phospholipid. Such hydrogen bonding has been 
shown to be important o the behavior of bilayers of 
derivatized phosphatidylethanolamine [16]. It was not a 
result of an L,~-H. phase transition, the phase boundary 
for which has been reported at a significantly higher 
temperature for the pure lipid [17]. The L,~-H n transition 
temperature for phosphatidylethanolamines is increased by 
the presence of ZfFG [6]. 
It can be speculated that ZfFG is likely on the surface 
of the membrane, perhaps with its hydrophobic phenyl 
rings extending toward the hydrophobic part of the mem- 
brane, and not immobilized, when it is inhibiting mem- 
brane fusion and the formation of highly curved phospho- 
lipid assemblies. ZfFG is not likely tightly bound to a 
phospholipid, in a 1:1 or 1:2 complex or similar, but is 
more likely rapidly exchanging among sites on the mem- 
brane surface. Thus, while it takes about 25 mol% to 
obtain the maximal effect of the peptide on function, 
nevertheless, that is probably less peptide than would be 
required if a tight complex with phospholipid was formed. 
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